Publicaties

Dijkstra BAG, van Oort M.  2017.  Handleiding Detoxificatie van psychoactieve middelen. Verantwoord ambulant of intramuraal detoxificeren. Resultaten Scoren.

Verbrugge CAG, Stollenga M..  2017.  Herstelondersteuning in Nederland: een stand van zaken. Naar een herstelondersteunende verslavingszorg. :18.

de Jong MArts-, DeJong CA, Hermens RP, Kissane DW, Massuger LM, Hoogerbrugge N, Prins JB, deHullu JA.  2017.  High demoralization in a minority of oophorectomized BRCA1/2 mutation carriers influences quality of life.. J Psychosom Obstet Gynaecol. :1-9.

van Lier H.G., Pieterse M.E., Schraagen J.M.C., Postel M.G., Vollenbroek-Hutten M.M.R., de Haan H.A., Noordzij M.L..  2017.  Identifying viable theoretical frameworks with essential parameters for real-time and real world alcohol craving research: a systematic review of craving models. . Addiction Research & Theory.

Luteijn I., Didden R, VanDerNagel JEL.  2017.  Individuals with Mild Intellectual Disability or Borderline Intellectual Functioning in a Forensic Addiction Treatment Center: Prevalence and Clinical Characteristics, Advances in Neurodevelopmental Disorders. Advances in Neurodevelopmental Disorders. :240-251.

Kiewik M, VanDerNagel JEl, Engels RCME, DeJong CA.  2017.  Intellectually disabled and addicted: a call for evidence based tailor-made interventions.. Addiction. 112(11):2067-2068.

van Oosterhout e, DeFuentes-Merillas L, Verbrugge CAG, de Feijter A, Franzek E.  2017.  Langdurig gedwongen ketenzorg onder onafhankelijke regie: een oplossing voor complexe casuistiek. Tijdschrift voor Verslaving. DOI 10.1007/s12501-017-0119-9

Montfoort K, de Weert-van Oene GH, Beurmanjer H, Koekkoek B.  2017.  Late-onset alcohol dependence: patient-reported problems. Addiction Research & Theory . 25(2)

Schellekens A, Luijten M, Sescousse G.  2017.  Neuroimaging meta-analyses across psychiatric disorders: challenges and promises. Jama Psychiatry.

Chye Y, Solowij N, Suo C, Batalla A, Cousijn J, Goudriaan AE, Martin-Santos R, Whittle S, Lorenzetti V, Yücel M.  2017.  Orbitofrontal and caudate volumes in cannabis users: a multi-site mega-analysis comparing dependent versus non-dependent users.. Psychopharmacology (Berl).

Kamal RM, van Noorden MS, Wannet W, Beurmanjer H, Dijkstra BAG, Schellekens A.  2017.  Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention. CNS Drugs. 31(1):51-64.

van Noorden MS, Kamal R, Beurmanjer H, Dijkstra BAG, Schellekens AFA.  2017.  [Reaction on 'Hypernatremia caused by treatment with GHB obtained via a doctor's prescription'].. Tijdschr Psychiatr. 59(3):195-196.

Dijkstra BAG, van Oort M, Schellekens A, De Haan HA, DeJong CA.  2017.  Richtlijn detoxificatie van psychoactieve middelen. Verantwoord ambulant of intramuraal detoxificeren. Resultaten Scoren.

Chye Y, Solowij N, Ganella EP, Suo C, Yücel M, Batalla A, Cousijn J, Goudriaan AE, Martin-Santos R, Whittle S et al..  2017.  Role of orbitofrontal sulcogyral pattern on lifetime cannabis use and depressive symptoms.. Prog Neuropsychopharmacol Biol Psychiatry. 79(Pt B):392-400.

Batalla A, Homberg JR, Lipina TV, Sescousse G, Luijten M, Ivanova SA, Schellekens A, Loonen AJM.  2017.  The role of the habenula in the transition from reward to misery in substance use and mood disorders.. Neurosci Biobehav Rev.

Wits E, Croes E, Dijkstra BAG, van Nattum M.  2017.  Standaarden bieden houvast aan alle zorgverleners. Medisch Contact.

Swerts C, Vandevelde S, VanDerNagel JEl, Vanderplasschen W, Claes C, De Maeyer J.  2017.  Substance use among individuals with intellectual disabilities living independently in Flanders.. Res Dev Disabil. 63:107-117.

VanDerNagel JEl, Kiewik M, van Dijk M, Didden R, Korzilius HPLM, van der Palen J, Buitelaar JK, Uges DRA, Koster RA, DeJong CA.  2017.  Substance use in individuals with mild to borderline intellectual disability: A comparison between self-report, collateral-report and biomarker analysis.. Res Dev Disabil. 63:151-159.

VanDerNagel JEL, Kiewik M, Didden R, Korzilius HPLM, van Dijk M, van der Palen J, Buitelaar JK, de Jong CAJ.  2017.  Substance use in individuls with mild to borderline intellectual disability: An exploration of Risks and Rates in the Netherlands. Advances in Neurodevelopmental Disorders. 1(4):283-293.

van Noorden MS, Mol T, Wisselink J, Kuijpers W, Dijkstra BAG.  2017.  Treatment consumption and treatment re-enrollment in GHB-dependent patients in The Netherlands. Drug Alcohol Depend. 176:96-101.

Ter Huurne ED, Postel MG, de Haan HA, van der Palen J, de Jong CAJ.  2017.  Treatment dropout in web-based cognitive behavioral therapy for patients with eating disorders.. Psychiatry Research. 247

Ter Huurne ED, Postel MG, de Haan HA, van der Palen J, de Jong CAJ.  2017.  Treatment dropout in web-based cognitive behavioral therapy for patients with eating disorders.. Psychiatry Research. 247

Wieferink C.E.M., de Haan H.A., Dijkstra B.A.G., Fledderus M., Kok T..  2017.  Treatment of substance use disorders: Effects on patients with higher or lower levels of PTSD symptoms.. Addictive Behaviors. 74

Kok T., de Haan H.A., Sensky T., van der Meer M., De Jong C.A.J..  2017.  Using the Pictorial Representation of Illness and Self Measure (PRISM) to Quantify and Compare Suffering From Trauma and Addiction.. Journal of Dual Diagnosis . 13(2)

Kok T..  2017.  Using the Pictorial Representation of Illness and Self Measure (PRISM) toe Quantify and Compare Suffering From Trauma and Addiction. Journal of Dual Diagnosis. 13(2)